38 /100
MEDIUM RISK
Score updated May 30, 2026

MAZE — Maze Therapeutics, Inc. Dilution Risk Tracker

Track MAZE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MAZE — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
9%
💰 Capital Raise 18%
• Active ATM program with $200M remaining capacity
🔔 Track MAZE — Get forecast alerts →

💹 Market Data

Market Cap$1.46B
Shares Outstanding55.35M
Float37.18M
Cash$352.38M
Debt$61.22M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 12.8% shares (2025Q4 vs prior)
144 institutional holders · 48.60M shares
#1 Frazier Life Sciences Management, L.P. 4.57M shares
#2 TRV GP IV, LLC 4.47M shares
#3 Deep Track Capital, LP 4.25M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.95M
Days to Cover7.4
% of Float10.6%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2025
8-K 8K EVENT Apr 22, 2026
424B5 ATM Apr 22, 2026
4 INSIDER TRANSACTION Apr 02, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track MAZE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MAZE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for MAZE
📊 MAZE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MAZE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.